March 09, 2011 -- De Facto, part of Open Health and Chime Communications’ international network, has been appointed by Sepmag to create a strong brand profile for the company as a manufacturer of unique precision magnetophoresis systems targeted at the in vitro diagnostics market.
The communications brief comprises both a digital search engine optimisation component, combined with the implementation of an extensive news and features focused media campaign. De Facto has developed a communications programme designed to establish and build solid awareness of the company and its novel technology amongst key target audiences including US, pan European and Asian based key opinion leaders, specialist scientific personnel and relevant procurement decision makers in the in vitro diagnostics manufacturing ector. A core objective of the profile raising campaign is to facilitate new business opportunities and the company’s marketing and sales initiatives.
De Facto Communications Associate Director, Tristan Jervis, who leads the account commented: “We are delighted to be providing digital and media communications support for Sepmag. Our central task is to ensure that all key target audiences in focused international markets are made readily aware of the key benefits of using the company’s unique magnetic separation technologies and the implications that this has for significantly enhancing the in vitro diagnostics market. Above all, we will ensure that clear and scientifically accurate messaging about the company and its offering is both communicated and is properly accessible and available on-line and in all prepared press materials”.
Josep Maria Simo, Chief executive of Sepmag commented: “We are pleased to be working with De Facto Communications. They have both a strong network of international diagnostics and broader life science media contacts, whilst at the same time possessing strong industry knowledge and therefore the capability to properly communicate scientific language through their skilful communications techniques. On the digital optimisation front, they also apply their understanding of the in vitro diagnostic market and technical terminology to ensure that our company features prominently and is accessible under all the relevant search terms. We look forward to developing a strong relationship with this dynamic and informed agency.”
For further information please contact Tristan Jervis at De Facto Communications on: + 44 (207) 861 3019 or t.jervis@defacto.com.
Visit the De Facto Communications site at www.defacto.com
For more info please contact:
Tristan Jervis, Associate Director, De Facto Communications on: 00 44 207 861 3019 or e-mail : t.jervis@defacto.com
About De Facto Communications
De Facto Communications, part of Open Health and Chime Communications Plc’s international network, is the consultancy of choice for the best strategic life science and healthcare communications. De Facto has been a leader in its field for over 20 years and its reputation for informed, honest advice, backed by effective service delivery is second to none.
Its experienced teams have constructed and implemented marketing, design, digital, financial and PR communications campaigns through out Europe, the US, the Middle East and Asia - utilising the Chime Communications Group’s international network. The specialist offering includes website enhancement, brochure, logo and strap line design, SEO, key messaging and positioning refinement, investor relations including trade sales and listings, corporate, financial, B2B and B2C media communications and medical education support.
